Understanding autism and other neurodevelopmental disorders: From the embryo to brain organoids

  • Autism Research
Speaker Paola Arlotta, Ph.D.
Harvard University
Date & Time


Tea:
4:15 - 5:00pm
Lecture:
5:00 - 6:15pm

Location

Gerald D. Fischbach Auditorium
160 5th Avenue
New York, NY 10010 United States

Autism Research

Autism Research lectures bring together scientists and scholars to discuss diverse and important topics related to autism. The lectures are open to the public and are held at the Gerald D. Fischbach Auditorium at the Simons Foundation headquarters in New York City. Tea is served prior to each lecture.

Video replay of this event will be available shortly. Please check back at a later date.

On 1 November 2017, Paola Arlotta focused on the cerebral cortex and presented the challenges and opportunities of modeling human brain development using pluripotent stem cells within 3D human brain organoids. Building on developmental work in mice, such organoids promise a better understanding of complex neurodevelopmental conditions such as autism spectrum disorder.

Her talk was part of the Simons Foundation Autism Research lecture series.

About the Lecture

The cellular and molecular processes that control brain development in mammals, as well as how neurodevelopmental disorders affect such processes, remain poorly understood. The recent advent of brain organoids (lab-grown clusters of living neurons) offers new ways to study the relationships between neurodevelopmental disorders and brain development.

In this lecture, Paola Arlotta focused on the cerebral cortex and presented the challenges and opportunities of modeling human brain development using pluripotent stem cells within 3D human brain organoids. Building on developmental work in mice, such organoids promise a better understanding of complex neurodevelopmental conditions such as autism spectrum disorder. She discussed her recent work on the generation and long-term development of human brain organoids and the study of their developmental trajectories, cellular diversities and neuronal network features.

Arlotta then showed that phenotypic abnormalities observed in patients carrying genetic mutations linked to autism spectrum disorder can be reproduced within brain organoids. This work serves as a proof-of-principle demonstration that selected aspects of human neurodevelopmental conditions can be modeled in vitro with the goal of better understanding disease genetics and pathology.

About the Speaker

Paola Arlotta is a professor of stem cell and regenerative biology at Harvard University. She is a principal faculty member at the Harvard Stem Cell Institute, where she is co-director of the neuroscience program, an institute member at the Broad Institute, and an associate member of the Stanley Center for Psychiatric Research at the Broad Institute. She is interested in understanding the molecular laws that govern the birth, differentiation and assembly of the human brain’s cerebral cortex. The complexity of the brain fascinates her and she is driven to integrate developmental and evolutionary knowledge to investigate therapies for brain repair and for modeling neuropsychiatric disease. Arlotta received her M.S. in biochemistry from the University of Trieste, Italy, and her Ph.D. in molecular biology from the University of Portsmouth in the UK. She subsequently completed her postdoctoral training in neuroscience at Harvard Medical School.

Past Lectures

On the road to precision health: Brain-based biomarkers in autism spectrum disorder

Shafali Spurling Jeste, M.D.Associate Professor in Psychiatry, Neurology and Pediatrics, UCLA David Geffen School of Medicine
Director, Developmental Neurophysiology Lab, UCLA Center for Autism Research and Treatment

On 7 February 2018, Shafali Spurling Jeste provided a topical overview of the current state of research in autism biomarkers. She shared data from studies of autism biomarkers in three key areas: early risk prediction (studies of high-risk infants), heterogeneity within the autism spectrum and genetically defined subgroups within autism. Finally, she discussed the challenges around clinical trial design and development and considered how more objective measures of brain function can improve clinical trials.

Arousal, emotion regulation and challenging behaviors: Insights from the Autism Inpatient Collection

Matthew Siegel, M.D.Associate Professor of Psychiatry and Pediatrics, Tufts University
Vice President, Medical Affairs, Developmental Disorders Service, Maine Behavioral Healthcare

On 24 January 2018, Matthew Siegel drew upon a new resource, the Autism Inpatient Collection data set, to offer preliminary insights into the relationships between physiologic arousal, emotion dysregulation and the occurrence of challenging behaviors. Such behaviors may represent an attempt to modulate physiologic arousal in minimally verbal individuals with autism spectrum disorders.

Autism genetics: Searching for coherence

Daniel Geschwind, M.D., Ph.D.Professor, University of California, Los Angeles

On 28 November 2017, Daniel Geschwind discussed his group’s use of RNA sequencing, chromatin structure and gene networks to help develop an understanding of potential convergent mechanisms in autism spectrum disorders.

Subscribe to our newsletter and receive SFARI funding announcements and news